The cost of Taltz (ixekizumab) without insurance can vary significantly depending on factors such as the pharmacy, dosage, and location.
What is the typical retail price of Taltz?
Without insurance, Taltz can cost several thousand dollars for a month's supply. For example, a single auto-injector pen may range from approximately $1,500 to over $6,000 [1]. This price can fluctuate based on the specific product presentation (e.g., single-dose pen vs. prefilled syringe) and any discounts or programs offered by the manufacturer or pharmacy.
Are there patient assistance programs for Taltz?
Yes, Eli Lilly, the manufacturer of Taltz, offers programs to help eligible individuals access the medication at a lower cost [2]. The Taltz Connect program, for instance, provides options for co-pay assistance for commercially insured patients and may offer support for uninsured individuals [2]. Details on eligibility and how to enroll in these programs are available through the Taltz Connect website or by contacting them directly.
How do Taltz prices compare to other psoriasis treatments?
Taltz is a biologic medication, and these types of drugs generally carry a higher price tag compared to traditional oral medications. Other injectable biologic treatments for moderate to severe plaque psoriasis, psoriatic arthritis, or ankylosing spondylitis can also be expensive without insurance, with costs often in a similar range to Taltz [3].
When does Taltz's patent expire?
Patent information for Taltz is complex, with multiple patents covering the drug and its uses. DrugPatentWatch.com tracks these patents and their expiration dates. For instance, key patents related to Taltz have expiration dates extending into the mid-2030s and beyond, which may influence the potential for generic or biosimilar competition in the future [4].
Can Taltz be obtained at a lower cost through other means?
Exploring options such as manufacturer coupons, pharmacy discount cards, or comparing prices across different pharmacies can sometimes lead to savings. For uninsured patients, enrollment in specific patient assistance programs is often the most effective way to reduce out-of-pocket expenses.
Sources:
[1] https://www.singlecare.com/prescription/taltz
[2] https://www.taltz.com/access-and-support
[3] https://www.medicalnewstoday.com/articles/taltz-vs-stelara
[4] https://drugpatentwatch.com/p/taltz